From September 13th to 14th, FUSCC delegation attended the 11th FUSCC-CRIKU Joint academic exchange events which was convened at University of Kanazawa, Japan. The delegation was composed of Professor Huijuan Yang, from Department of Gynecologic Oncology, Professor Chen Yong, from Department of Musculoskeletal Oncology and Professor Tong Tong, from Department of Radiology, FUSCC. During their visit, they engaged in the fruitful discussions with Japanese researchers and students.

In order to promote the development of basic research and clinical translational research, the 11th FUSCC-CRIKU Joint Symposium on Tumor Biology was held at Kanazawa. Professor Shinichi NAKAMURA, Vice President of University of Kanazawa, Japan, delivered the opening address, extending his warm welcome and expressed heartfelt gratitude to the speakers and participants.

The symposium focused on the cutting-edge topics include basic research, precision Medicine, drug development and 6 speakers from China and Japan presented outstanding academic insights. Notably, Professor Huijuan Yang, Professor Tong Tong, and Professor Yong Chen sequentially unveiled their latest research achievements within their respective fields. The content of their presentations encompassed a diverse range of subjects, including studies on the activation mechanisms of the PI3K pathway in gynecological cancers and the ongoing clinical trials concerning pathway inhibitors. A prognostic value of the consensus molecular subtype4 (CMS4) predicted by multipara metric radiomics-based machine learning in colorectal cancer: a multi-center retrospective study and the effect of the potential new drug MIT inhibitor on malignant melanoma and its synergistic mechanism with anti-PD1 immunotherapy. The academic atmosphere resonated with robust academic enthusiasm, with audiences actively participating through thought-provoking questions and discussions.

As part of FUSCC-CRIKU academic exchange initiatives, a series of in-depth discussions and workshops took place on the morning of September 14th. These discussions involved three FUSCC representatives engaging with esteemed counterparts from University of Kanazawa, namely Professor Chiaki TAKAHASHI, Professor Takeshi SUZUKI, and Professor Yoshikazu JOMURA. The discussions centered on the functionality of the p16 gene in relation to aging and tumor fibrosis, as well as its intricate connections with immunotherapy. Preliminary experimental plans were meticulously explored, focusing on melanoma and sarcoma. Both parties emerged from these discussions with a unanimous consensus to deepen communication and establish further collaborations in this pivotal field of research.